| 000 | 01305 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250516130625.0 | ||
| 264 | 0 | _c20130611 | |
| 008 | 201306s 0 0 eng d | ||
| 022 | _a1940-6029 | ||
| 024 | 7 |
_a10.1007/978-1-62703-230-8_18 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZimmer, Danna B | |
| 245 | 0 | 0 |
_aIn vivo screening of S100B inhibitors for melanoma therapy. _h[electronic resource] |
| 260 |
_bMethods in molecular biology (Clifton, N.J.) _c2013 |
||
| 300 |
_a303-17 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aDrug Screening Assays, Antitumor _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMaximum Tolerated Dose |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNerve Growth Factors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aS100 Calcium Binding Protein beta Subunit |
| 650 | 0 | 4 |
_aS100 Proteins _xantagonists & inhibitors |
| 700 | 1 | _aLapidus, Rena G | |
| 700 | 1 | _aWeber, David J | |
| 773 | 0 |
_tMethods in molecular biology (Clifton, N.J.) _gvol. 963 _gp. 303-17 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-1-62703-230-8_18 _zAvailable from publisher's website |
| 999 |
_c22399952 _d22399952 |
||